Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiping Fan

Showing results (111-120 of 152) with videos related to

Pageof 16
Sort By:
Bone Marrow Transplantation|September 2, 2022
Allogeneic hematopoietic stem cell transplantation overcome the poor prognosis of patients with IKZF1plus CD20-a very high-risk subtype in B-cell acute lymphoblastic leukemiaBingqing Tang, Zihong Cai, Zhixiang Wang, et al.
British Journal of Haematology|January 3, 2024
Adoptive therapy with cytomegalovirus-specific cytotoxic T lymphocytes for refractory cytomegalovirus DNAemia and disease after allogeneic haematopoietic stem cell transplantationZhonghui Jiang, Zhiping Fan, Tian Zhang, et al.
Cancer|March 7, 2018
Effect of sorafenib on the outcomes of patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantationLi Xuan, Yu Wang, Fen Huang, et al.
Journal of Hematology & Oncology|March 14, 2020
Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective dataSijian Yu, Fen Huang, Zhiping Fan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2019
Sorafenib Therapy Is Associated with Improved Outcomes for FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell TransplantationLi Xuan, Yu Wang, Jia Chen, et al.
Transplantation and Cellular Therapy|September 1, 2022
Haplo-Peripheral Blood Stem Cell Plus Cord Blood Grafts for Hematologic Malignancies Might Lead to Lower Relapse Compared with Haplo-Peripheral Blood Stem Cell Plus Bone Marrow GraftsFen Huang, Xiangzong Zeng, Zhiping Fan, et al.
Oncoimmunology|July 29, 2016
Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantationXinmiao Jiang, Lanping Xu, Yu Zhang, et al.
BMC Medicine|August 27, 2025
Fecal microbiota transplantation for refractory chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation: a pilot open-label, non-placebo-controlled studyKaibo Yang, Jing Du, Fen Huang, et al.
BMC Medicine|September 1, 2022
Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trialXin Xu, Zhiping Fan, Yu Wang, et al.
Chinese Medical Journal|April 25, 2022
Haploidentical transplantation has a superior graft-versus-leukemia effect than HLA-matched sibling transplantation for Ph- high-risk B-cell acute lymphoblastic leukemiaMenglin Fan, Yu Wang, Ren Lin, et al.
Pageof 16

Showing results (111-120 of 152) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|September 2, 2022
Allogeneic hematopoietic stem cell transplantation overcome the poor prognosis of patients with IKZF1plus CD20-a very high-risk subtype in B-cell acute lymphoblastic leukemiaBingqing Tang, Zihong Cai, Zhixiang Wang, et al.
British Journal of Haematology|January 3, 2024
Adoptive therapy with cytomegalovirus-specific cytotoxic T lymphocytes for refractory cytomegalovirus DNAemia and disease after allogeneic haematopoietic stem cell transplantationZhonghui Jiang, Zhiping Fan, Tian Zhang, et al.
Cancer|March 7, 2018
Effect of sorafenib on the outcomes of patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantationLi Xuan, Yu Wang, Fen Huang, et al.
Journal of Hematology & Oncology|March 14, 2020
Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective dataSijian Yu, Fen Huang, Zhiping Fan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2019
Sorafenib Therapy Is Associated with Improved Outcomes for FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell TransplantationLi Xuan, Yu Wang, Jia Chen, et al.
Transplantation and Cellular Therapy|September 1, 2022
Haplo-Peripheral Blood Stem Cell Plus Cord Blood Grafts for Hematologic Malignancies Might Lead to Lower Relapse Compared with Haplo-Peripheral Blood Stem Cell Plus Bone Marrow GraftsFen Huang, Xiangzong Zeng, Zhiping Fan, et al.
Oncoimmunology|July 29, 2016
Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantationXinmiao Jiang, Lanping Xu, Yu Zhang, et al.
BMC Medicine|August 27, 2025
Fecal microbiota transplantation for refractory chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation: a pilot open-label, non-placebo-controlled studyKaibo Yang, Jing Du, Fen Huang, et al.
BMC Medicine|September 1, 2022
Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trialXin Xu, Zhiping Fan, Yu Wang, et al.
Chinese Medical Journal|April 25, 2022
Haploidentical transplantation has a superior graft-versus-leukemia effect than HLA-matched sibling transplantation for Ph- high-risk B-cell acute lymphoblastic leukemiaMenglin Fan, Yu Wang, Ren Lin, et al.
Pageof 16